Arkolith/Insider Trading/SNTI/Form 4

Rajangam Kanya

Pres. & Chief Med. & Dev. Off.Senti Biosciences, Inc. (SNTI) · full profile →Form 4 · filed Dec 10, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
0 non-derivative · 2 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 9, 2024Grant(A)33$2250.00$74K33
Dec 9, 2024Grant(A)50K—$050K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001854270-24-000121) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML